With a Duchenne MD patient struggling for life, little Akashi suspends study

John Carroll

Nonprofit-backed Therapeutics has suspended a trial of its lead drug for muscular dystrophy after a on the highest dose experienced "-threatening health issues."

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS